Thyroid Cancer Trial, Recruiting NCT07226804 Sponsor: M.D. Anderson Cancer Center Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07226804
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are already scheduled to have a specific thyroid treatment procedure (called nsPFA) guided by ultrasound as part of your normal care
  • You are between 18 and 80 years old
  • You are able to give your own consent to take part without assistance
  • You have a thyroid nodule (a lump in the thyroid gland) that has been confirmed as non-cancerous (benign) through biopsy testing, meeting one of these conditions:
    • Two separate needle biopsy tests have both shown it is benign, OR
    • One ultrasound-guided needle biopsy showed it is benign AND the nodule looks benign on ultrasound scan, OR
    • One needle biopsy showed it is benign AND imaging or blood tests suggest the nodule is functioning in a certain way (confirm with trial site)
  • The thyroid nodule measures more than 2 centimetres at its widest point
  • You are experiencing symptoms caused by the nodule pressing on nearby structures, such as a feeling of pressure in the neck, difficulty swallowing, changes to your voice, or breathing difficulties
  • You have no abnormal lymph nodes in your neck at the time of your screening appointment

Who may not be able to join:

  • You are under 18 years old
  • Your treating doctor has decided that the nsPFA procedure is not suitable for you for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victoria E Banuchi, MD, M.D. Anderson Cancer Center

Phone: 346-217-8668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 November 2025
Est. completion
31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Quality-of-life Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov